|
KR20070101867A
|
|
Methods for the biotransformation of the clyclosporin compound isa247
|
|
BRPI0517207A
|
|
isolated compound, isolated cyclo {{(e) - and (z) - (2s, 3r, 4r) -3-hydroxy-4-methyl-2- (methylamino) -6,8-nonadien oil} -1- 2-Aminobutyryl-n-methyl-glycyl-n-methyl-1-leucyl-lv-allyl-n-methyl-1-leucyl-1-alanyl-d-alanyl-n-methyl-1-leucyl-n-methyl-1 -leucyl-n-methyl-1-valyl} (isa247) and their pharmaceutically acceptable salts and solvates, method of preparing isa247 metabolites in vitro, method of producing an isa247 hydroxylated metabolite, isolated isa247 hydroxylated metabolite, isolated hydroxylated metabolite, method of producing an isa247 epoxide metabolite in vitro, isolated isa247 epoxide metabolite, isolated epoxide metabolite, method of producing an isa247 diol metabolite in vitro, isa247 isolated diol metabolite, metabolite diol isolated, method of producing an isa247 diol metabolite, method of producing an isa247 diol metabolite and pharmaceutical composition
|
|
US2005176628A1
|
|
Deuterated cyclosporin analogs and their use as immunomodulating agents
|
|
CN1823081A
|
|
Rapamycin carbohydrate derivatives
|
|
US7160867B2
|
|
Rapamycin carbohydrate derivatives
|
|
TWI330643B
|
|
Cyclosporine analogue mixtures and their use as immunomodulating agents
|
|
YU33204A
|
|
Synthesis of cyclosporin analogs
|
|
YU32904A
|
|
Novel cyclosporin analog microemulsion preconcentrates
|
|
IL160762D0
|
|
Cyclosporin analogue mixtures and their use as immunomodulating agents
|
|
TWI324073B
|
|
Pharmaceutical compositions comprising novel cyclosporin analogs and methods for preparing the same
|
|
YU33004A
|
|
Cyclosporine analogue mixtures and their use as immuno modulating agents
|
|
EP1435910A1
|
|
Novel cyclosporin analog microemulsion preconcentrates
|
|
CA2461740A1
|
|
Synthesis of cyclosporin analogs
|
|
AU2756702A
|
|
Deuterated cyclosporine analogs and their use as immunomodulating agents
|
|
US6511988B2
|
|
Activated iododerivatives for the treatment of cancer and aids
|
|
US6461870B2
|
|
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
|
|
US6334997B1
|
|
Method of using deuterated calcium channel blockers
|
|
US6333342B1
|
|
Methods of pharmacological treatment using S(−) amlodipine
|
|
EP1121383A1
|
|
Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites
|
|
US6686454B1
|
|
Antibodies to specific regions of cyclosporine related compounds
|
